BK-specific T-cell therapy (University of Wisconsin-Madison)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBK-specific T-cell therapy (University of Wisconsin-Madison)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsRejection of renal transplantationPolyomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin-Madison
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Wisconsin-Madison
Inactive CompaniesN/A
Active IndicationsRejection of renal transplantationPolyomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A